Do GLP-1-Based Therapies Increase Cancer Risk?

Diabetes Care - United States
doi 10.2337/dcs13-2004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Do Statins Increase and Mediterranean Diet Decrease the Risk of Breast Cancer?

BMC Medicine
Medicine
2014English

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Gastroenterology
HepatologyGastroenterology
2011English

Sweet Foods Increase Breast Cancer Risk

BMJ
2005English

GLP-1 Based Therapeutics: Simultaneously Combating T2DM and Obesity

Frontiers in Neuroscience
Neuroscience
2015English

Fracture Risk and Adjuvant Therapies in Young Breast Cancer Patients: A Population-Based Study

PLoS ONE
Multidisciplinary
2015English

Do Incretin-Based Therapies Cause Acute Pancreatitis?

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2010English

A Nationwide Population-Based Cohort Study: Will Anxiety Disorders Increase Subsequent Cancer Risk?

PLoS ONE
Multidisciplinary
2012English

Increase Cancer Risk in Patients With Primary Hyperparathyroidism

American Journal of Otolaryngology and Head and Neck Surgery
2019English

MTOR Inhibitor-Based Combination Therapies for Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy